ALEMBIC PHARMACEUTICALS LTD. - 533573 - US FDA Inspection At Alembic Pharmaceuticals Limited' Solid Oral Formulation Facility (F-4) At Jarod

Alembic Pharmaceuticals Ltd.

NSE: APLLTD | BSE: 533573 | ISIN: INE901L01018 | Industry: Pharmaceuticals
| Mid-range Performer

947.3000 0.80 (0.08%)

NSE Sep 08, 2025 15:31 PM

27.35% Fall from 52W High

Volume: 48,747

Alembic Pharmaceuticals Ltd.

23 Nov 2024

947.30

0.08%

Company Update

ALEMBIC PHARMACEUTICALS LTD. - 533573 - US FDA Inspection At Alembic Pharmaceuticals Limited' Solid Oral Formulation …

BSE India

Please find attached the intimation for USFDA Inspection at Company''s Solid Oral Manufacturing Facility (F-4) at Jarod.

More from Alembic Pharmaceuticals Ltd.

Recommended

IPOs this week: Seven upcoming listings, Urban Company plus ten new issues

| 08 Sep 2025, 05:30PM

Market closes higher, Ujjivan SFB plans to raise around Rs 2,000 crore via a QIP

Trendlyne Marketwatch | 08 Sep 2025, 03:59PM

Earnings Call Transcript - Q1FY21 for Alembic Pharmaceuticals